Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen; L. S. Gasbjerg; M. M. Rosenkilde; B. Hartmann; T. Vilsboll; J. J. Holst; M. B. Christensen; F. K. Knop

doi:10.1007/s00125-021-05519-y

Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen, L. S. Gasbjerg, M. M. Rosenkilde, B. Hartmann, T. Vilsboll, J. J. Holst, M. B. Christensen, F. K. Knop

Research output: Contribution to journal › Conference abstract in journal › Research

Original language	English
Article number	179
Journal	Diabetologia
Volume	64
Issue number	SUPPL 1
Pages (from-to)	95-95
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-021-05519-y
Publication status	Published - 2021

Access to Document

10.1007/s00125-021-05519-yLicence: Unspecified

Cite this

Stensen, S., Gasbjerg, L. S., Rosenkilde, M. M., Hartmann, B., Vilsboll, T., Holst, J. J., Christensen, M. B., & Knop, F. K. (2021). Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes. Diabetologia, 64(SUPPL 1), 95-95. [179]. https://doi.org/10.1007/s00125-021-05519-y

Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes. / Stensen, S.; Gasbjerg, L. S.; Rosenkilde, M. M.; Hartmann, B.; Vilsboll, T.; Holst, J. J.; Christensen, M. B.; Knop, F. K.

In: Diabetologia, Vol. 64, No. SUPPL 1, 179, 2021, p. 95-95.

Research output: Contribution to journal › Conference abstract in journal › Research

@article{972bbf7922d74636be88c32f6454b302,

title = "Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes",

author = "S. Stensen and Gasbjerg, {L. S.} and Rosenkilde, {M. M.} and B. Hartmann and T. Vilsboll and Holst, {J. J.} and Christensen, {M. B.} and Knop, {F. K.}",

year = "2021",

doi = "10.1007/s00125-021-05519-y",

language = "English",

volume = "64",

pages = "95--95",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "SUPPL 1",

}

TY - ABST

T1 - Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

AU - Stensen, S.

AU - Gasbjerg, L. S.

AU - Rosenkilde, M. M.

AU - Hartmann, B.

AU - Vilsboll, T.

AU - Holst, J. J.

AU - Christensen, M. B.

AU - Knop, F. K.

PY - 2021

Y1 - 2021

U2 - 10.1007/s00125-021-05519-y

DO - 10.1007/s00125-021-05519-y

M3 - Conference abstract in journal

C2 - 34468792

VL - 64

SP - 95

EP - 95

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - SUPPL 1

M1 - 179

ER -